hasTargetDisease
P20980
predicate
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
All labels observed (20)
| Label | Occurrences |
|---|---|
| therapeuticArea | 219 |
| hasTherapeuticArea | 67 |
| targetsDisease | 20 |
| targetDisease | 18 |
| studiesDisease | 8 |
| diseaseArea | 6 |
| therapeuticTargetIn | 5 |
| surveillanceFocusDiseases | 4 |
| diseaseTarget | 3 |
| diseaseTargeted | 2 |
| hasFocusDisease | 2 |
| treatsDiseaseArea | 2 |
| actsOnDisease | 1 |
| combinedWithFlucytosineUsedFor | 1 |
| coveredDisease | 1 |
| diseaseBurdenAddressed | 1 |
| hasFDAIndicationText | 1 |
| hasPrimaryDiseaseFocus | 1 |
| hasTargetDisease canonical | 1 |
| relatedToDisease | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasTargetDisease
Generated description
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
Sample triples (364)
| Subject | Object |
|---|---|
| Eisai and Biogen | dementia via predicate surface "therapeuticArea" ⓘ |
| Eisai and Biogen | neurodegenerative diseases via predicate surface "therapeuticArea" ⓘ |
| EMERGE (Study 302) | neurology via predicate surface "therapeuticArea" ⓘ |
| EMERGE (Study 302) | neurodegenerative diseases via predicate surface "therapeuticArea" ⓘ |
| ENGAGE (Study 301) | neurology via predicate surface "diseaseArea" ⓘ |
| ENGAGE (Study 301) | neurodegenerative disorders via predicate surface "diseaseArea" ⓘ |
| ENGAGE (Study 301) | Alzheimer’s disease via predicate surface "therapeuticArea" ⓘ |
| Trulicity | endocrinology via predicate surface "hasTherapeuticArea" ⓘ |
| Trulicity | diabetology via predicate surface "hasTherapeuticArea" ⓘ |
| Zepbound | obesity treatment via predicate surface "therapeuticArea" ⓘ |
| Zepbound | metabolic disorders via predicate surface "therapeuticArea" ⓘ |
| Verzenio | oncology via predicate surface "therapeuticArea" ⓘ |
| Emgality | neurology via predicate surface "therapeuticArea" ⓘ |
| Emgality | headache disorders via predicate surface "therapeuticArea" ⓘ |
| onasemnogene abeparvovec | neuromuscular disease via predicate surface "hasTherapeuticArea" ⓘ |
| onasemnogene abeparvovec | rare disease via predicate surface "hasTherapeuticArea" ⓘ |
|
riluzole
surface form:
Riluzole
|
amyotrophic lateral sclerosis via predicate surface "actsOnDisease" ⓘ |
| Waylivra | rare lipid disorders via predicate surface "therapeuticArea" ⓘ |
| Waylivra | metabolic diseases via predicate surface "therapeuticArea" ⓘ |
| Sanofi | diabetes via predicate surface "therapeuticArea" ⓘ |
| Sanofi | cardiovascular diseases via predicate surface "therapeuticArea" ⓘ |
| Sanofi | oncology via predicate surface "therapeuticArea" ⓘ |
| Sanofi | immunology via predicate surface "therapeuticArea" ⓘ |
| Sanofi | rare diseases via predicate surface "therapeuticArea" ⓘ |
| SMN2 | spinal muscular atrophy type 1 via predicate surface "therapeuticTargetIn" ⓘ |
| SMN2 | spinal muscular atrophy type 2 via predicate surface "therapeuticTargetIn" ⓘ |
| SMN2 | spinal muscular atrophy type 3 via predicate surface "therapeuticTargetIn" ⓘ |
| Decision to provide ivermectin (Mectizan) free of charge for river blindness | onchocerciasis via predicate surface "targetsDisease" ⓘ |
| Decision to provide ivermectin (Mectizan) free of charge for river blindness | river blindness via predicate surface "targetsDisease" ⓘ |
|
GDF
surface form:
Global Drug Facility
|
infectious diseases via predicate surface "diseaseArea" ⓘ |
|
GDF
surface form:
Global Drug Facility
|
tuberculosis via predicate surface "diseaseArea" ⓘ |
| Novartis | oncology via predicate surface "therapeuticArea" ⓘ |
| Novartis | cardiovascular diseases via predicate surface "therapeuticArea" ⓘ |
| Novartis | immunology via predicate surface "therapeuticArea" ⓘ |
| Novartis | neuroscience via predicate surface "therapeuticArea" ⓘ |
| Novartis | ophthalmology via predicate surface "therapeuticArea" ⓘ |
| AIM | malaria via predicate surface "targetsDisease" ⓘ |
| Alkermes | schizophrenia via predicate surface "therapeuticArea" ⓘ |
| Alkermes | bipolar disorder via predicate surface "therapeuticArea" ⓘ |
| Alkermes | major depressive disorder via predicate surface "therapeuticArea" ⓘ |
| Alkermes | opioid dependence via predicate surface "therapeuticArea" ⓘ |
| Alkermes | alcohol dependence via predicate surface "therapeuticArea" ⓘ |
| fampridine | neurology via predicate surface "hasTherapeuticArea" ⓘ |
| World Health Organization smallpox eradication program | smallpox via predicate surface "targetDisease" ⓘ |
| Chugai Pharmaceutical | oncology via predicate surface "hasTherapeuticArea" ⓘ |
| Chugai Pharmaceutical | rheumatology via predicate surface "hasTherapeuticArea" ⓘ |
| Chugai Pharmaceutical | hemophilia via predicate surface "hasTherapeuticArea" ⓘ |
| Pharmaceuticals Division | oncology via predicate surface "therapeuticArea" ⓘ |
| Pharmaceuticals Division | immunology via predicate surface "therapeuticArea" ⓘ |
| Pharmaceuticals Division | infectious diseases via predicate surface "therapeuticArea" ⓘ |